Spanish pharma deal & funding model fillip for medtech?
This article was originally published in Clinica
Executive Summary
The Spanish pharmaceutical industry has reached an agreement with the government, said to be worth up to Pta442.5 billion ($2.5 billion) to the healthcare system in savings on medicine prices and investments in healthcare research in 2002-04. The deal will go some way to appeasing the devices industry, which has long borne the brunt of financial shortfalls at the expense of pharma spending.